View previous page | Backgrounds Home Page | View next page
Figure 22 The production of bovine somatotropin (BST) through genetic engineering. Although BST is functional, harmless, and sanctioned by the FDA, much controversy exists over whether it is actually desirable.
The list of gene modifications that directly aid consumers will only grow. In Holland, Dutch bioengineers announced last month that they are genetically engineering plants to act as vaccine-producing factories! To petunias they have added a gene for a vaccine against dog parvovirus, hiding the gene within the petunia genes that direct nectar production. The drug is produced in the nectar, collected by bees, and extracted from the honey. It is hard to believe this isn't science fiction. Clearly, the real promise of plant genetic engineering lies ahead, and not very far. Farm Animals The gene encoding the growth hormone somatotropin was one of the first to be cloned successfully. In 1994 Monsanto received federal approval to make its recombinant bovine somatotropin (BST) commercially available, and dairy farmers worldwide began to add the hormone as a supplement to their cows' diets, increasing the animals' milk production (figure 22). Genetically engineered somatotropin is
Transgenic animals engineered to have specific desirable genes are becoming increasingly available to breeders. Now, instead of selectively breeding for several generations to produce a racehorse or a stud bull with desirable qualities, the process can be shortened by simply engineering such an animal right at the start. Gene technology is revolutionizing agriculture, increasing yields and resistance to pests, and producing animals with desirable traits.
|
|
|||||||||||||||||||||||||||||||||||||